N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide

C32H33N9O5 — CID 164845957

IUPACN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide
SMILESCc1ccccc1-c1ccccc1C(=O)NC1CN2C(N)=N[C@@H](CN3C(=O)CN(c4ccccc4)C3=O)[C@@H]3N=C(N)N[C@@]32C1(O)O
InChIInChI=1S/C32H33N9O5/c1-18-9-5-6-12-20(18)21-13-7-8-14-22(21)27(43)36-24-16-41-29(34)35-23(26-31(41,32(24,45)46)38-28(33)37-26)15-40-25(42)17-39(30(40)44)19-10-3-2-4-11-19/h2-14,23-24,26,45-46H,15-17H2,1H3,(H2,34,35)(H,36,43)(H3,33,37,38)/t23-,24?,26-,31-/m0/s1
InChIKeyOAUGJQHHWDCXMP-WEMMFYFESA-N
MW623.67 g/mol
LogP-0.09
Rot. Bonds6

About N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide

N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide (PubChem CID 164845957) has the molecular formula C32H33N9O5 and a molecular weight of 623.67 g/mol. Its IUPAC name is N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide.

Molecular Properties

Compound NameN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide
PubChem CID164845957
Molecular FormulaC32H33N9O5
Molecular Weight623.67 g/mol
Exact Mass623.26
IUPAC NameN-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide
SMILESCc1ccccc1-c1ccccc1C(=O)NC1CN2C(N)=N[C@@H](CN3C(=O)CN(c4ccccc4)C3=O)[C@@H]3N=C(N)N[C@@]32C1(O)O
InChIInChI=1S/C32H33N9O5/c1-18-9-5-6-12-20(18)21-13-7-8-14-22(21)27(43)36-24-16-41-29(34)35-23(26-31(41,32(24,45)46)38-28(33)37-26)15-40-25(42)17-39(30(40)44)19-10-3-2-4-11-19/h2-14,23-24,26,45-46H,15-17H2,1H3,(H2,34,35)(H,36,43)(H3,33,37,38)/t23-,24?,26-,31-/m0/s1
InChIKeyOAUGJQHHWDCXMP-WEMMFYFESA-N
XLogP-0.09
TPSA202.21 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms46
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500623.67
LogP ≤ 5-0.09
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide?
The IUPAC name of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide (CID 164845957) is N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide.
What is the SMILES notation for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide?
The canonical SMILES for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide is Cc1ccccc1-c1ccccc1C(=O)NC1CN2C(N)=N[C@@H](CN3C(=O)CN(c4ccccc4)C3=O)[C@@H]3N=C(N)N[C@@]32C1(O)O.
What is the InChIKey of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide?
The InChIKey is OAUGJQHHWDCXMP-WEMMFYFESA-N. The full InChI is InChI=1S/C32H33N9O5/c1-18-9-5-6-12-20(18)21-13-7-8-14-22(21)27(43)36-24-16-41-29(34)35-23(26-31(41,32(24,45)46)38-28(33)37-26)15-40-25(42)17-39(30(40)44)19-10-3-2-4-11-19/h2-14,23-24,26,45-46H,15-17H2,1H3,(H2,34,35)(H,36,43)(H3,33,37,38)/t23-,24?,26-,31-/m0/s1.
What are the key properties of N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide?
N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide has a molecular weight of 623.67 g/mol, XLogP of -0.09, 6 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3aS,4S,10aS)-2,6-diamino-4-[(2,5-dioxo-3-phenylimidazolidin-1-yl)methyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2-(2-methylphenyl)benzamide is sourced from PubChem (CID 164845957), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).